Meanwhile, CAFs and HSCs activate pro-fibrotic and angiogenic pathways by secreting TGF-β and VEGF, driving fibrotic remodelling of the ECM and aberrant vasculogenesis, and providing biochemical scaffolds for HCC cell proliferation and invasion [63–65]. Here, TGFB1 is linked to hepatocellular carcinoma.